Clinical Trials Browser

OTHER × antineoplaston AS 2-1 × Genitourinary × Clear all

NCT00003516 2018-02-05

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms

NCT00003534 2018-01-31

Antineoplaston Therapy in Treating Patients With Refractory Stage IV Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms

NCT00003533 2017-12-12

Antineoplaston Therapy in Treating Patients With Metastatic Prostate Cancer

Phase 2 Terminated

Prostatic Neoplasms

NCT00003520 2017-09-29

Antineoplaston Therapy in Treating Patients With Stage IV Kidney Cancer

Phase 2 Terminated

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00003452 2017-09-28

Antineoplastons A10 and AS2-1 In Patients With Carcinoma of the Bladder

Phase 2 Terminated

Urinary Bladder Neoplasms